Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Gilead Sciences Inc (GILD)

  • Business News
  • June 25, 2025, 11:01 UTC

Gilead - Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders

Full text
Register to leave comments
There are no comments here yet...

Search

News categories

  • Technical Exchange News(9542)
  • Event(407)
  • SEC News(156360)
  • FDA Approval(8925)
  • Company Report(721)
  • Business News(106106)
© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin